Southeast Asset Advisors’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-13,971
Closed -$730K 236
2026
Q1
$730K Sell
13,971
-4,865
-26% -$292K 0.08% 116
2025
Q4
$1.11M Buy
18,836
+6,727
+56% +$409K 0.11% 100
2025
Q3
$674K Sell
12,109
-3,057
-20% -$164K 0.07% 118
2025
Q2
$780K Buy
15,166
+921
+6% +$46.3K 0.09% 101
2025
Q1
$835K Sell
14,245
-3,420
-19% -$232K 0.1% 97
2024
Q4
$1.27M Sell
17,665
-1,975
-10% -$145K 0.16% 74
2024
Q3
$1.57M Sell
19,640
-5,556
-22% -$417K 0.17% 69
2024
Q2
$1.81M Sell
25,196
-4,590
-15% -$338K 0.22% 61
2024
Q1
$2.1M Buy
29,786
+1,919
+7% +$137K 0.25% 57
2023
Q4
$2.15M Sell
27,867
-1,565
-5% -$103K 0.29% 50
2023
Q3
$2M Buy
29,432
+2,858
+11% +$226K 0.28% 48
2023
Q2
$2.17M Sell
26,574
-11,995
-31% -$964K 0.31% 49
2023
Q1
$2.86M Buy
38,569
+15
+0% +$1.16K 0.43% 34
2022
Q4
$3.2M Buy
38,554
+13,922
+57% +$1.11M 0.51% 34
2022
Q3
$1.75M Buy
24,632
+7,668
+45% +$663K 0.3% 49
2022
Q2
$1.47M Buy
16,964
+10,232
+152% +$959K 0.23% 59
2022
Q1
$729K Buy
+6,732
New +$695K 0.1% 95
2018
Q3
Sell
-7,464
Closed -$276K 111
2018
Q2
$276K Sell
7,464
-11,784
-61% -$450K 0.08% 96
2018
Q1
$727K Sell
19,248
-16,396
-46% -$579K 0.22% 54
2017
Q4
$1.15M Sell
35,644
-928
-3% -$29.5K 0.35% 43
2017
Q3
$1.1M Buy
36,572
+212
+0.6% +$6.29K 0.35% 39
2017
Q2
$1.07M Hold
36,360
0.35% 38
2017
Q1
$924K Hold
36,360
0.29% 46
2016
Q4
$935K Sell
36,360
-120
-0.3% -$3.15K 0.3% 44
2016
Q3
$999K Hold
36,480
0.34% 38
2016
Q2
$1.03M Sell
36,480
-1,920
-5% -$49.4K 0.34% 38
2016
Q1
$907K Buy
38,400
+23,600
+159% +$520K 0.3% 45
2015
Q4
$333K Buy
+14,800
New +$337K 0.11% 75

Other funds holding TECH

Southeast Asset Advisors's TECH Position: Q2 2026 in Review

Southeast Asset Advisors sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 13,971 shares — an estimated $730K sold.

Southeast Asset Advisors first reported a position in TECH in Q4 2015 and held it in 28 quarters. The position peaked at $3.2M in Q4 2022. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Southeast Asset Advisors reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
  • Southeast Asset Advisors sold 13,971 Bio-Techne shares in Q2 2026, an estimated $730K.
  • Southeast Asset Advisors first reported a position in Bio-Techne in Q4 2015 and held it in 28 quarters.
  • Southeast Asset Advisors's Bio-Techne position peaked at $3.2M in Q4 2022.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Southeast Asset Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.